Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps
The FDA has announced that Medtronic Plc (NYSE:MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic…
SVP General Counsel And Corporate Sec Of Medtronic Trades $10M In Company Stock
Bradley Lerman, SVP General Counsel And Corporate Sec at Medtronic (NYSE:MDT), made a large buy and sell of company shares on September 30, according to a new SEC filing.
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics,
Medtronic’s Radial Artery Access Portfolio Approved In Europe
Medtronic plc (NYSE:MDT) has received CE Mark approval for its radial artery access portfolio, including the Rist 079 Radial Access Guide…
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and…
Medtronic Reports US Patent & Trademark Office’s Patent Trial, Appeal Board Affirmed Added 3 Patents IN Disupte With Axonics Over Intellectual Property For ITs Sacral Neuromdoulation Device Family
Medtronic (NYSE:MDT), the global leader in medical technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed an additional three patents in a dispute
Medtronic Reports Commencement Of Pediatric Trial Of Spinal Tether For Treatment Of Scoliosis
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has enrolled its first patient and completed the first surgical procedure in its BRAIVE™ IDE study, which will evaluate the
Medtronic Recalls Pipeline Flex Embolization: What You Need To Know
Medtronic Plc (NYSE:MDT) is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology stents…
BioSig Expands in Electrophysiology with St. Elizabeth’s Medical Center Evaluation
Increasing its ever-growing presence in the cardiac electrophysiology space, BioSig Technologies (NASDAQ: BSGM) will be installing one of its new PURE EP systems in St. Elizabeth’s Medical Center in Boston for evaluation.